Antiphospholipid syndrome (APS) is an autoimmune disease characterized by arterial and venous thrombosis, recurrent abortions, and antiphospholipid antibodies (aPL). However, it is possible to find patients with clinical signs of APS who persistently test negative for aPL (seronegative APS, or SN-APS). The aim of this study was to identify new antigenic target(s) of autoantibodies in APS patients, which may also be recognized in SN-APS. We tested sera from patients with SN-APS with a proteomic approach by analyzing endothelial cell-surface membrane proteins. Sera from SN-APS patients revealed 2 reactive spots corresponding to vimentin, a protein that is shown to bind cardiolipin in vitro. Antivimentin/cardiolipin antibodies were tested in 29 SN-APS patients, 40APS patients, 30 patients with systemic lupus erythematosus, 30 with rheumatoid arthritis, 30 with venous or arterial thrombosis, and 32 healthy control patients. We observed that not only a large proportion of SN-APS patients but also almost all the APS patients displayed the presence of antivimentin/cardiolipin antibodies. To verify the possible pathogenic role of these autoantibodies, we demonstrated that affinity-purified antivimentin/cardiolipin antibodies induced interleukin receptor-associated kinase phosphorylation and nuclear factor-kappa B activation in endothelial cells. Our results prompt to identify vimentin as a "new" cofactor for aPL, which may represent a useful tool mainly in SN-APS patients. (Blood.2010;116(16):2960-2967)

Vimentin/cardiolipin complex as a new antigenic target of the antiphospholipid syndrome / E., Ortona; A., Capozzi; T., Colasanti; Conti, Fabrizio; Alessandri, Cristiano; Longo, Agostina; Garofalo, Tina; P., Margutti; Misasi, Roberta; M. A., Khamashta; G. R. V., Hughes; Valesini, Guido; Sorice, Maurizio. - In: BLOOD. - ISSN 0006-4971. - STAMPA. - 116:16(2010), pp. 2960-2967. [10.1182/blood-2010-04-279208]

Vimentin/cardiolipin complex as a new antigenic target of the antiphospholipid syndrome

A. Capozzi;T. Colasanti;CONTI, FABRIZIO;ALESSANDRI, cristiano;LONGO, Agostina;GAROFALO, TINA;MISASI, Roberta;VALESINI, Guido;SORICE, Maurizio
2010

Abstract

Antiphospholipid syndrome (APS) is an autoimmune disease characterized by arterial and venous thrombosis, recurrent abortions, and antiphospholipid antibodies (aPL). However, it is possible to find patients with clinical signs of APS who persistently test negative for aPL (seronegative APS, or SN-APS). The aim of this study was to identify new antigenic target(s) of autoantibodies in APS patients, which may also be recognized in SN-APS. We tested sera from patients with SN-APS with a proteomic approach by analyzing endothelial cell-surface membrane proteins. Sera from SN-APS patients revealed 2 reactive spots corresponding to vimentin, a protein that is shown to bind cardiolipin in vitro. Antivimentin/cardiolipin antibodies were tested in 29 SN-APS patients, 40APS patients, 30 patients with systemic lupus erythematosus, 30 with rheumatoid arthritis, 30 with venous or arterial thrombosis, and 32 healthy control patients. We observed that not only a large proportion of SN-APS patients but also almost all the APS patients displayed the presence of antivimentin/cardiolipin antibodies. To verify the possible pathogenic role of these autoantibodies, we demonstrated that affinity-purified antivimentin/cardiolipin antibodies induced interleukin receptor-associated kinase phosphorylation and nuclear factor-kappa B activation in endothelial cells. Our results prompt to identify vimentin as a "new" cofactor for aPL, which may represent a useful tool mainly in SN-APS patients. (Blood.2010;116(16):2960-2967)
2010
anticardiolipin syndrome; endothelial cell activation; systemic lupus erythematosus
01 Pubblicazione su rivista::01a Articolo in rivista
Vimentin/cardiolipin complex as a new antigenic target of the antiphospholipid syndrome / E., Ortona; A., Capozzi; T., Colasanti; Conti, Fabrizio; Alessandri, Cristiano; Longo, Agostina; Garofalo, Tina; P., Margutti; Misasi, Roberta; M. A., Khamashta; G. R. V., Hughes; Valesini, Guido; Sorice, Maurizio. - In: BLOOD. - ISSN 0006-4971. - STAMPA. - 116:16(2010), pp. 2960-2967. [10.1182/blood-2010-04-279208]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/229036
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 27
  • Scopus 88
  • ???jsp.display-item.citation.isi??? 74
social impact